Glucagon like peptide-1 similarly amplifies insulin secretion in late-onset type 1 and type 2 diabetes

Glucagon like peptide-1 similarly amplifies insulin secretion in late-onset type 1 and type 2 diabetes

Bibliographic Details
Main Authors:	Maksoud, H, Barrow, B, Sutton, P, Levy, J, Turner, R
Format:	Journal article
Published:	1999

Similar Items

PROLONGED INFUSION OF GLUCAGON-LIKE PEPTIDE-1 IN TYPE-2 DIABETES NORMALIZES INSULIN-RESPONSE TO GLUCOSE
by: Gribble, F, et al.
Published: (1995)

Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
by: Gromada, J, et al.
Published: (2004)

New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
by: Gromada, J, et al.
Published: (2004)

11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
by: Swali, A, et al.
Published: (2008)

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
by: Rachman, J, et al.
Published: (1996)

Calcium regulation of glucagon-like peptide-1 secretion.
by: Chua, Sharon Chia Ling.
Published: (2010)

Late onset type 1 diabetes.
by: Lasserson, D, et al.
Published: (2012)

Late onset type 1 diabetes
by: Lasserson, D, et al.
Published: (2012)

Late onset type 1 diabetes.
by: Lasserson, D, et al.
Published: (2012)

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.
by: Rachman, J, et al.
Published: (1997)

Pulsatile, synchronous basal insulin and glucagon secretion in man.
by: Lang, D, et al.
Published: (1982)

Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
by: Gromada, J, et al.
Published: (1997)

Role of synaptotagmin-7 in glucagon-like peptide (GLP-1) secretion.
by: Kang, Yvonne Yu Han.
Published: (2009)

SOMATOSTATIN AS A POSSIBLE MEDIATOR OF INSULIN AND GLUCAGON PULSATILE SECRETION
by: Frank, M, et al.
Published: (1987)

Stimulus-secretion coupling in L cells and factors affecting secretion of glucagon-like peptide 1
by: Cyranka, M
Published: (2023)

Desensitization of glucagon-like peptide 1 receptors in insulin-secreting beta TC3 cells: role of PKA-independent mechanisms.
by: Gromada, J, et al.
Published: (1996)

Similar proportional, in spite of differing absolute responses to non-glucose and glucose insulin secretagogues in Type 2 diabetic, LADA and non-diabetic subjects
by: Meston, N, et al.
Published: (2007)

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
by: Gromada, J, et al.
Published: (1998)

Insulin prevents counter-regulatory glucagon secretion by stimulation of somatostatin release
by: Rorsman, P, et al.
Published: (2013)

Molecular mechanism underlying glucagon-like peptide 1 induced calcium mobilization from internal stores in insulin-secreting beta TC3 cells.
by: Gromada, J, et al.
Published: (1996)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
by: Vergari, E, et al.
Published: (2019)

Somatostatin but not insulin is an important paracrine regulator of glucagon secretion in rat A-cells
by: Renstrom, E, et al.
Published: (1997)

PYY-dependent restoration of impaired insulin and glucagon secretion in type-2 diabetes following Roux-En-Y gastric bypass surgery
by: Ramracheya, R, et al.
Published: (2016)

The insulin receptor talks to glucagon?
by: Gromada, J, et al.
Published: (2009)

Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons.
by: Ma, X, et al.
Published: (2007)

GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P/Q-type Ca2+ channels
by: Ramracheya, R, et al.
Published: (2018)

GLP-1 and exendin-4 increase post-prandial leptin in type 2 diabetes
by: Stoeckli, R, et al.
Published: (2005)

Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells
by: Xu, W, et al.
Published: (2023)

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
by: Keymeulen, B, et al.
Published: (2005)

Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
by: Gromada, J, et al.
Published: (1995)

Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes.
by: Zhang, Q, et al.
Published: (2013)

Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment
by: Rasouli, Mina, et al.
Published: (2011)

Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
by: Herlihy, O, et al.
Published: (2002)

[Insulin secretion in non-insulin-dependent diabetes]
by: Turner, R, et al.
Published: (1991)

Insulin secretion in non-insulin-dependent diabetes
by: Turner, R, et al.
Published: (1991)

Molecular defects in insulin secretion in type-2 diabetes.
by: Ashcroft, F, et al.
Published: (2004)

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.
by: Armstrong, M, et al.
Published: (2015)

[Late-onset-Typ-1-diabetes].
by: Lasserson, D, et al.
Published: (2012)

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
by: Nielsen, L, et al.
Published: (2007)

In normoglycaemic siblings of type 2 diabetic patients, obesity accounts for decreased insulin sensitivity but not for hypertension.
by: Levy, J, et al.
Published: (1998)